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In humans and most animal models, the development of obesity leads not only to 
increased fat depots in classical adipose tissue locations, but also to significant lipid 
deposits within and around other tissues and organs, a phenomenon known as ectopic fat 
storage.  The purpose of this review is to explore the possible locations of ectopic fat in 
key target-organs of cardiovascular control (heart, blood vessels and kidneys) and to 
propose how ectopic fat storage can play a role in the pathogenesis of cardiovascular 
diseases associated with obesity.  In animals fed a high-fat diet, cardiac fat depots within 
and around the heart impair both systolic and diastolic functions, and may in the long 
term promote heart failure.  Accumulation of fat around blood vessels (perivascular fat) 
may affect vascular function in a paracrine manner, as perivascular fat cells secrete 
vascular relaxing factors, pro-atherogenic cytokines and smooth muscle cell growth 
factors.  Furthermore, high amounts of perivascular fat could mechanically contribute to 
the increased vascular stiffness seen in obesity.  Finally, accumulation of fat in the renal 
sinus may limit the outflow of blood and lymph from the kidney, which would alter 
intrarenal physical forces and promote sodium reabsorption and arterial hypertension.  
Taken together, ectopic fat storage in key target-organs of cardiovascular control may 
impair their functions, contributing to the increased prevalence of cardiovascular diseases 
in obese subjects.  
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In humans and most animal models, the development of obesity leads not only to 
increased fat depots in classical adipose tissue locations, but also to significant lipid 
deposits within and around other tissues and organs (ectopic fat storage).  With fat gain, 
lipid deposition can impair tissue and organ function in two possible ways.  First, the size 
of fat pads around key organs may increase substantially.  This could modify organ 
function either by simple physical compression or because periorgan fat cells may secrete 
various locally acting substances.  Second, lipid accumulation can occur in non-adipose 
cells and may lead to cell dysfunction or cell death, a phenomenon known as 
lipotoxicity.1,2  Intracellular lipid accumulations in endocrine pancreas, liver and skeletal 
muscle cells have all been described and contribute to the pathogenesis of impaired 
insulin secretion and insulin resistance, respectively.  Ectopic fat deposition may also 
affect renal and cardiovascular function.  The purpose of this review is to explore the 
possible locations of ectopic fat in key target-organs of cardiovascular control (heart, 
blood vessels and kidneys) and propose how ectopic fat storage can play a role in the 
pathogenesis of cardiovascular diseases. 
In the last few years,3-8 a new animal model of obesity, the rabbit fed a high-fat 
diet has allowed us to study many of the mechanisms of obesity-associated cardiovascular 
pathologies.  Ad libitum access to high-fat diet for 8-12 weeks led to a more than 3-fold 
increase in percent fat content determined by carcass analysis and lipid extraction, from 
10% in lean rabbits to about 34% in obese rabbits.9  Fat depots occurred largely in the 
retroperitoneal space, in the neck, shoulder girdle and the subcutaneous suprapubic 
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region.  Smaller increases were seen in the mesentery, in the mediastinum, along blood 
vessels and in other scattered locations.  Obese rabbits also gain lean mass.  Indeed, as 
shown in Figure 1, all organs tested gained in weight with most of the gain due to an 
increase in lean mass (non-fat solids) plus the water obligated to that mass.  There was 
considerable fat accretion in the renal sinus, the renal structure that starts from the hilum 
and intrudes upon the renal parenchyma. 
Compared to lean rabbits, obese rabbits exhibit a higher 24-h blood pressure 
(+15%) and heart rate (+30%),6 increased cardiac output,3 cardiac diastolic dysfunction5,10 
and abnormal diurnal cardiovascular rhythms.8  Obese rabbits also exhibit neurohormonal 
changes with hyperinsulinemia, elevated plasma triglyceride levels and increased activity 
of the sympathetic nervous system and the renin-angiotensin system.4  Finally, obese 
rabbits show abnormal sodium handling with marked sodium retention during the 
development of obesity despite an elevated glomerular filtration rate.6,7  Similar findings 
are observed when dogs are fed a high-fat diet for several weeks.11,12  A model of obesity 
based solely on intake of a high-fat diet is relevant to the development of obesity in many 
situations in humans.  Because obese dogs and rabbits exhibit many of the characteristics 
of obesity in humans, including hypertension, insulin resistance, humoral activation, 
increase in lean body mass and cardiac hypertrophy, they serve as a good model to study 
the cardiovascular effects of ectopic fat storage. 
 
Ectopic fat storage in the heart 
 
Most animal models of obesity as well as obese humans show an increased cardiac 
mass.  In the rabbit model of obesity, a 50% gain in body weight led to an increase in dry 
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weight of the right and left ventricles by about 70% and 50%, respectively, and to an 
increase in protein content by about 50% in both right and left ventricles.4  Since there 
were no significant alterations in total DNA content, these data suggest that weight gain 
causes cardiac myocyte hypertrophy.  There was also a nearly 2-fold increase of fat 
weight for both ventricles, which appears to be caused primarily by increased depots in 
the fat pads around the base of ventricles.  Overall, those changes led to significant 
alterations in cardiac function.  Study of the end-diastolic pressure-volume relationship in 
isolated hearts of lean and obese rabbits at different end-diastolic volumes shows a 
marked decrease in diastolic compliance.5  In itself, stiffer ventricles will impair cardiac 
function.  A higher filling pressure is required to expand ventricles to ensure adequate 
filling and contraction.  The concurrent increase in atrial pressures not only impairs 
venous return to the heart, but also increases intramyocardial capillary pressures and 
favors cardiac wall edema.13  In dogs, we have demonstrated that weight-gain with a 
high-fat diet for 4 weeks led to a significant increase in left atrial pressure, both at rest 
and more importantly during exercise, and to a net decrease in exercise tolerance.12   In 
addition, obese rabbit hearts exhibit mild systolic dysfunction with a reduced contractile 
responsiveness to isoproterenol.14 
To what extent the cardiac changes observed in obesity are due to ectopic fat 
storage is not clear.  Indeed, as illustrated in Figure 2, the causes of cardiac dysfunction in 
obesity are complex.  It could be postulated that some of the cardiac changes result from 
the hypertension often observed in obesity.15  However, the increase in blood pressure is 
often very mild and is thus unlikely to cause by itself important structural cardiac 
changes.  Furthermore, decrements in systolic and diastolic functions have been 
documented in obese subjects even in the absence of hypertension.16  Indeed, the 
Framingham study has determined that obesity is an independent risk factor for 
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congestive heart failure.17  Another possible cause of cardiac dysfunction in obesity could 
be related to the consistent increase in cardiac output seen in obesity.  The increase in 
both fat and organ masses raises whole body metabolic demands and thus regional blood 
flows.3  In turn, cardiac output, the sum of all regional blood flows, increases (+37% in 
obese rabbits), putting an additional work load on the heart.  Although experimental 
models of high-output heart failure, following the opening of an arteriovenous fistula for 
example, usually require larger increases in cardiac output (2-3 fold increase) for heart 
failure to develop, the contributing load of a moderately increased cardiac output, 
however, cannot be excluded.  Indeed, the arteriovenous fistula of hemodialysis patients 
accounts for an about 30% increase in cardiac output, and its closure in stable renal 
transplant patients can significantly decrease left ventricular mass.18  Finally, the 
combination of mild elevation of systolic blood pressure along with increased heart rate 
increases the double product (heart rate-pressure product), a determinant of myocardial 
oxygen consumption.19,20  Since weight gain leads to a reduced parasympathetic control 
of heart rate with a decreased baroreflex gain,21 small intermittent increases in blood 
pressure are not balanced by adequate decreases in heart rate and further increase heart 
work. 
As shown in Figure 2, a contributory role of ectopic fat storage in the pathogenesis 
of cardiac dysfunction is suggested for the following reasons:  (1) Accumulation of fat 
pads around ventricles (within a poorly distensible pericardium) may theoretically 
increase ventricular stiffness and thus contribute to diastolic dysfunction.  To our 
knowledge, there are, however, no studies that have specifically addressed this point.  (2) 
More importantly, weight gain may lead to intramyocytic deposits of lipids.  Cardiac lipid 
accumulation has been observed in various rodent models of obesity.  First, hearts from 
Zucker diabetic fatty (ZDF) fa/fa rats, a strain of rats characterized by leptin receptor 
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deficiency, severe obesity and hyperinsulinemia, exhibit an elevation in myocardial 
triglyceride and ceramide contents that can be partially reversed by treatment with the 
antisteatotic drug troglitazone.22  ZDF rats have also a poor systolic function (as assessed 
by cardiac circumferential fractional shortening), which can be reversed by troglitazone 
treatment started early in life.  It is postulated that the accumulation of large amounts of 
triglycerides may trigger a pathological signaling cascade resulting in apoptosis and 
systolic dysfunction.  Second, hearts from obese, leptin-deficient, ob/ob mice showed 
marked accumulation of neutral lipid droplets within cardiac myocytes.23  In those mice, 
systolic function was only marginally affected, but there was a clear association between 
cardiac lipid accumulation and diastolic dysfunction.  Finally, myocardial lipid content is 
also increased in lean Zucker rats fed a high-fat diet and is associated with myocardial 
oxidative injury.24  As for obese humans, lipid excess in the myocardium, as assessed by 
magnetic resonance spectroscopy, has been demonstrated and correlates with left 
ventricular mass and systolic dysfunction.25   
In summary, genetic rodent models of obesity and diet-induced obesity in rodents 
and humans show cardiac lipid accumulation within myocytes.  However, the quantitative 
contribution of cardiac lipotoxicity in the pathogenesis of cardiac dysfunction is not 
known. In fact, the combination of a mild increase in blood pressure, increase in cardiac 
output, increase in the heart rate-pressure product, and ectopic fat storage within and 
around the heart, could have additive effects resulting in the frequent observation of 
systolic and diastolic dysfunctions in obesity, which in the long term promote heart 
failure.  In the follow-up of participants in the Framingham Heart Study, increased body-
mass index was associated with an increased risk of heart failure.26  Given the high 
prevalence of obesity, it is not surprising that there is today a growing epidemic of heart 
failure.27  Furthermore, the poorer exercise tolerance in obesity, due to the combination of 
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cardiac dysfunction, increased whole body metabolic demands and weight-induced osteo-
articular problems, may further potentiate obesity, leading to a vicious cycle of inactivity, 
weight gain and heart failure.15 
 
Ectopic fat storage around blood vessels 
 
Nearly all blood vessels in the body are surrounded by variable amounts of 
adventitial fat.  Traditionally, perivascular fat has been assumed to serve as structural 
support for the vasculature.  However, perivascular fat has been shown to modulate 
vascular responsiveness to vasoactive agents in ex-vivo studies of the aorta28,29 and of the 
mesenteric vessels.30  Interestingly, diet-induced fat deposition in experimental models of 
obesity is not limited to the subcutaneous fat and to the classical visceral depots in tight 
connection with mediastinic and abdominal organs, but also occurs along the major blood 
vessels.9  In rats, high-fat feeding resulted in a 2-fold increase in the mass of perivascular 
adipose tissue.31  Obese Zucker fa/fa rats have also significantly more periaortic fat than 
their lean littermates, even when periaortic fat is normalized to body weight.32 
The pathophysiological consequences of increased perivascular fat in obesity are 
depicted in Figure 3.  A first consequence could simply be mechanical.  As more adipose 
tissue wraps around blood vessels, it is conceivable that the large amounts of perivascular 
fat could contribute to the increased vascular stiffness often observed in obese subjects.  
Although most vascular elasticity studies in humans have been conducted in small and 
medium size vessels accessible to ultrasonography, the vascular properties of large 
vessels in obese subjects have also been investigated.  Excess body weight is associated 
with higher aortic stiffness as determined by magnetic resonance imaging techniques33 or 
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by aortic pulse wave velocity measurements.34  What is worrisome is that the strength of 
this association can be seen in very young adults.34  In fact, non-invasive measurements 
of the carotid artery by ultrasound imaging in severely obese children revealed a 
significantly greater carotid stiffness.35  Here again, it is not known to what extent 
perivascular fat contributes to the increased vascular stiffness.  Other factors, such as 
obesity-induced hypertension, endothelial dysfunction, insulin resistance, higher 
sympathetic activity, the low-grade inflammation state of obesity36 and possibly lipid 
accumulation within vascular smooth muscle cells,37 may all contribute to the increased 
vascular stiffness of obesity.  Whatever the cause, the loss of vascular distensibility has 
dramatic influences on cardiac function.  A stiffer aorta per se increases pulse pressure 
simply because the aortic pressure changes created by ventricular ejection are no longer 
damped by an effective Windkessel function.  A stiffer aorta also increases pulse wave 
velocity.  Peripheral reflection waves return much quicker to the heart, increasing blood 
pressure during systole and no longer during diastole.  As a consequence, there is a 
secondary elevation of systolic blood pressure (a phenomenon known as augmentation), 
which puts an additional work load on the heart.  Furthermore, since the majority of left 
coronary blood flow occurs during diastole, the decrease in diastolic blood pressure may 
impair coronary blood flow reserve. 
In addition, perivascular fat could act as secretory organ to influence the 
neighboring blood vessels.  This function of perivascular fat is very intriguing since 
studies in isolated blood vessels have shown that the contractile response of rat aortic 
rings to angiotensin II, serotonin and phenylephrine was significantly attenuated in the 
presence of periadventitial fat.29  This effect is independent of nitric oxide formation and 
appears to be mediated by a transferable relaxing factor that is released by periadventitial 
vascular adipose tissue.  Yet, it is not known whether this apparently beneficial effect of 
Montani et al., Ectopic fat storage in key cardiovascular organs 10 
periadventitial fat could be impaired under certain pathological conditions.  On the other 
hand, perivascular fat could have adverse effects, as shown on Figure 3, by releasing 
growth factors acting on the adjacent vascular smooth muscle cells (VSMC) or by 
secreting pro-atherogenic cytokines. 
A plausible adipocyte-derived vascular growth factor is angiotensin II, a small 
peptide that has, among many other effects, vascular mitogenic and pro-inflammatory 
properties.38  Indeed, adipocytes can produce and release angiotensinogen and may have 
the complete enzymatic machinery for local production of angiotensin II.39  Furthermore, 
abdominal visceral fat has been shown to express more angiotensinogen than does 
subcutaneous fat.40  However, it is not known whether perivascular adipocytes can release 
angiotensinogen or angiotensin II in significant amounts to diffuse to and affect 
neighboring VSMC.  Another growth factor candidate could be leptin, which has been 
shown to stimulate VSMC proliferation and migration.41  However, leptin expression is 
higher in subcutaneous fat than in visceral fat, and its effect on vascular growth may be 
mediated via circulating levels.  In a study in 294 healthy adolescents with a broad range 
of body mass indexes, higher serum leptin concentrations were associated with impaired 
arterial distensibility, independently of fat mass or blood pressure.42  Intriguingly, leptin-
deficient ob/ob mice or leptin-receptor deficient db/db mice are relatively resistant to 
atherosclerosis despite being obese, hyperlipidemic and diabetic.43  Furthermore, carotid 
artery injury combined with cholesterol and high-fat diet in ob/ob or db/db mice failed to 
induce significant neointimal thickening whereas the same treatment was very effective in 
wild-type mice.44  To complicate the matter, obese subjects are known to develop leptin 
resistance; the role of leptin in promoting atherosclerosis in diet-induced obesity is 
therefore not clear. 
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Other vascular growth factors could be involved.  In cell culture experiments, 
adipose-conditioned medium stimulates the growth of human VSMC via a factor that is 
heat- and trypsin-resistant.32  Perivascular adipose-tissue conditioned medium is also 
capable of promoting VSMC growth.32  The growth-stimulating effect was more 
pronounced when using periaortic fat from older rats (24 months) than from younger rats 
(3 months).  Therefore, adipocyte-derived VSMC growth factors could be involved in 
vascular remodeling, particularly in ageing.  Furthermore, as this effect is dose-
dependent, higher amounts of perivascular fat could lead to more intense remodeling. 
Alternatively, vascular growth could be promoted by a relative lack of growth 
inhibitors.  For example, there is compelling evidence that adiponectin, a protein which is 
exclusively and abundantly produced by adipocytes,45 has a protective role in 
cardiovascular disease.46  In addition to its strong anti-inflammatory and anti-atherogenic 
properties, adiponectin suppresses VSMC proliferation and migration and could be an 
important modulator of vascular remodeling.47  Since obese subjects and patients with 
type 2 diabetes have low levels of plasma adiponectin,46 a postulated decreased secretion 
of adiponectin by perivascular adipocytes could promote vascular hypertrophy. 
Finally, perivascular adipocytes could play a role in the progression of vascular 
dysfunction and atherosclerosis via secretion of various pro-inflammatory cytokines.  
Obesity is being increasingly recognized as a low-grade inflammatory state.36  Features of 
acute-phase activation and low-grade inflammation, including elevated circulating levels 
of fibrinogen, C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-
6 (IL-6) have been associated with (central) obesity.48  Positive association between body 
mass index and CRP has been described both in adults49 and children.50  The prevailing 
view is that inflammatory cytokines, which are released by adipose tissue, exert the pro-
atherogenic effects via the systemic circulation by acting on leucocytes and endothelial 
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cells.  An alternate and emerging concept is that perivascular adipocytes could promote 
vascular dysfunction and atherosclerosis via a paracrine secretion of various pro-
inflammatory cytokines, in particular certain pro-atherogenic chemokines 
(chemo(attractant cyto)kines). In fact, VSMC are potential targets for chemokines as they 
possess a number of functional chemokine receptors.51  In addition, aortic smooth muscle 
cells have been shown to produce CRP in response to inflammatory cytokines.52 
Perivascular adipose tissue is tightly bound to the wall of large arteries, 
particularly around the aortic arch, the abdominal aorta and the iliac bifurcation, which 
are predilection sites for atherogenesis in humans.  Since the adventitial tissue that 
separates perivascular fat from the media is usually relatively thin (100-200 µm), it is 
postulated that chemokines produced by perivascular adipocytes might easily diffuse to 
the neighboring vascular media and thereby contribute to the progression of 
atherosclerosis.  In general, adipose tissue has been shown to secrete various pro-
atherogenic chemokines, such as interleukin-8 (IL-8) and monocyte chemoattractant 
protein-1 (MCP-1).  In fact, visceral abdominal fat produces 2-3 fold more IL-8 than does 
subcutaneous abdominal fat.53  In addition, a recent study has reported that the pro-
atherogenic chemokines RANTES (Regulated on Activated Normal T-cell Expressed and 
Secreted) and interferon-γ-inducible protein-10 (IP-10) can be produced by human white 
adipose tissue explants, and that expression of these two chemokines is upregulated in 
obese patients.31  RANTES promotes plaque formation and antagonism of RANTES 
receptors reduces atherosclerotic plaque formation in low-density lipoprotein receptor-
deficient mice fed a high-cholesterol diet.54  IP-10 has mitogenic effects on VSMC and is 
a chemoattractant protein for lymphocytes and monocytes.55  A higher expression of IP-
10 in perivascular fat of obese patients could contribute to vascular stiffness and 
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atherosclerosis.  Whether perivascular fat can produce all these pro-inflammatory 
mediators awaits further exciting studies.  
In summary, perivascular adipose tissue is in close connection with the media of 
blood vessels, separated from it only by a very thin adventitial layer.  The mass of 
perivascular fat increases in obesity and it is postulated that a paracrine secretion of 
various growth-stimulating and pro-inflammatory agents could contribute to the 
pathogenesis of cardiovascular diseases. 
 
Ectopic fat storage in the kidney 
 
The development of obesity-induced hypertension in dogs11 and rabbits7 is 
associated with significant sodium retention in spite of a marked increase in glomerular 
filtration rate (GFR).  Analysis of renal artery pressure-sodium excretion relationship in 
obese dogs fed a HFD for 5-6 weeks reveals a shift to the right as well as a decrease of 
the slope of the pressure-natriuresis curve.56  Many mechanisms (reviewed in Ref. 15) 
have been suggested to explain this abnormal sodium handling, including increased renal 
nerve sympathetic activity, activation of the renin-angiotensin-aldosterone system, as well 
as direct sodium-retaining effects of insulin.  In addition, there is evidence that weight 
gain is associated with abnormal physical forces within the kidney that could promote 
sodium retention.57  Measurement of renal interstitial fluid hydrostatic pressure (RIHP) in 
obese dogs show elevated values of about 19 mmHg in comparison to values of 9-10 
mmHg in lean dogs. Although small increases in RIHP tend to oppose tubular 
reabsorption forces, larger increases tend to compress medullary vasa recta and tubules, 
reducing vasa recta blood flow and tubular flow through the distensible loop of Henle.  
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As postulated by Hall et al.,57 the resulting increase in tubular transit time combined with 
the decrease in medullary blood flow promotes fluid and sodium reabsorption.  In turn, 
this would decrease NaCl delivery to the macula densa, contributing to the increased GFR 
and renin secretion observed in obesity. 
 The mechanisms by which weight-gain leads to abnormal intrarenal physical 
forces are complex, but could be related to the marked structural renal changes observed 
in animal models of diet-induced obesity (dogs, rabbits).  As shown in Figure 1, obese 
rabbits have larger kidneys (+30%) and large fat deposits in the renal sinus.9  There was 
no detectable fat accumulation by extraction procedures within the renal parenchyma, but 
rather within the renal sinus.  The renal sinus is the renal structure that starts from the 
hilum and intrudes upon the renal parenchyma, yet is physically separated from it by a 
reflection of the external capsule,58 as shown in the schematic diagram of Figure 4.  
Within this space, loose connective tissue surrounds renal blood and lymphatic vessels as 
well as the ureter. 
As fat accretion fills the renal sinus, compression of various renal structures may 
occur.  Compression of the inner medulla is likely since it is not protected by the renal 
fibrous capsule that corsets the entire kidney.  Intriguingly, the content of interstitial 
hyaluronan, a space filling molecule normally found in the renal inner medulla,59 is 
markedly increased in obese dogs60 and rabbits.61  The expansion of the hyaluronan-filled 
extracellular matrix between vasa recta and thin Henle tubules, evidenced with PAS and 
Alcian blue staining on histological section of the medulla,61 may thus contribute to the 
compression of medullary structures.  The mechanisms by which obesity results in 
increased intrarenal medullary hyaluronan are not known. 
In addition, fat deposition within the renal sinus may compress the renal vein and 
renal lymphatic vessels, all easily compressible structures.  Renal vein constriction results 
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in increases in renal interstitial pressure.62  The increase in RIHP is much greater in 
situations of volume expansion and is then accompanied by a net decrease in fractional 
sodium excretion63 with a nearly doubling of the transit time through the loop of Henle.64  
Since obesity is characterized by plasma volume expansion, one could speculate that the 
combination of slightly elevated vena caval pressure and renal vein constriction may 
contribute to the tendency for sodium retention during the development of obesity.  In 
addition, renal lymphatic compression may be involved.  Selective acute obstruction to 
renal lymphatic output increases kidney volume.65  Renal vein constriction increases 
kidney volume and renal lymph flow,65 which may serve to attenuate the increase in 
RIHP.  Although renal lymph vessels and the renal vein are probably only mildly 
compressed by sinus lipomatosis, one cannot exclude additive effects and more serious 
increases in RIHP than would have been observed by constriction of each structure 
separately. 
Furthermore, intra-abdominal pressure, which is directly related to the degree of 
abdominal adiposity,66 may amplify the compression due to renal sinus lipomatosis.   In 
lean rabbits, the kidneys lay partially submersed in the ventral surface of the 
retroperitoneal fat.  In obese rabbits, fat completely surrounds the kidneys, although well 
separated from the renal parenchyma by the fibrous capsule.  Increased retroperitoneal fat 
and increased abdominal pressure could prevent the fat accreted in the renal sinus from 
expanding outwards and may thereby further restrict the renal outflow of urine, blood and 
lymph, thus elevating RIHP. 
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Summary and conclusions 
 
Obesity is one of the most serious health problems in industrialized societies.  The 
increase in morbidity and mortality associated with weight gain results primarily from 
increased cardiovascular diseases such as stroke, coronary artery disease, congestive heart 
failure and chronic renal failure.  Obesity-associated cardiovascular diseases have a 
complex, multifactorial origin.  Arterial hypertension, which may be present in up to 50% 
of obese individuals, and metabolic problems with diabetes and dyslipidemia, whose 
prevalences increase dramatically with weight gain, are certainly major contributors.  
Accumulation of fat within and around key-organs of cardiovascular control may also 
affect their functions.  Increased epicardial fat pads associated with intramyocardial lipid 
deposition may lead to both systolic and diastolic dysfunctions.  Accumulation of fat 
within the renal sinus associated with the increased intra-abdominal pressure of visceral 
obesity may compress the renal papilla, the renal vein and lymphatics vessels, altering 
intrarenal physical forces that favor sodium reabsorption and arterial hypertension.  
Finally, very promising is the emerging concept that accumulation of fat around blood 
vessels (perivascular fat) may promote vascular remodeling and atherosclerosis via a 
paracrine secretion of smooth muscle cell growth regulators and pro-atherogenic 
cytokines.  Taken together, ectopic fat storage in key target-organs of cardiovascular 
control may contribute to the increased prevalence of cardiovascular diseases in obese 
subjects. 
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Fig 1 Obesity-related gain in the mass of organ/tissues in rabbits fed a high-fat diet.  
The bar chart represents the percent increase in total mass for each organ or 
tissue studied.  Each bar is further broken according to chemical composition: 
tissue water, defined as the weight lost after drying; fat, defined as the weight 
loss after extraction by organic solvents; and lean mass, which is the weight after 
drying and organic extraction. 
 
Fig 2 Postulated mechanisms by which diet-induced obesity may contribute to cardiac 
dysfunction. Hemodynamic changes with increases in blood pressure (BP), 
cardiac output (CO) and double product (DP) play an important role, but ectopic 
fat both around the ventricles and within cardiomyocytes probably worsens 
cardiac function. 
 
Fig 3 Postulated mechanisms by which increased perivascular adipose tissue during 
weight gain may contribute to the development, maintenance or aggravation of 
cardiovascular diseases. 
 
Fig 4 Schematic diagram of a unipapillate kidney typical of a rabbit, rat or mouse, 
illustrating how accumulation of fat in the renal sinus (sinus lipomatosis) may 
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